SAKAR

Sakar Healthcare Share Price

₹287.60 -6.3 (-2.14%)

21 Nov, 2024 14:11

SIP TrendupStart SIP in SAKAR

Start SIP

Performance

  • Low
  • ₹286
  • High
  • ₹291
  • 52 Week Low
  • ₹280
  • 52 Week High
  • ₹479
  • Open Price₹289
  • Previous Close₹294
  • Volume58,224

Investment Returns

  • Over 1 Month -9.5%
  • Over 3 Month -8.8%
  • Over 6 Month -18.3%
  • Over 1 Year -24.53%
SIP Lightning

Smart Investing Starts Here Start SIP with Sakar Healthcare for Steady Growth!

Invest Now

Sakar Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 49.5
  • PEG Ratio
  • -3.6
  • Market Cap Cr
  • 614
  • P/B Ratio
  • 2.3
  • Average True Range
  • 11.58
  • EPS
  • 5.7
  • Dividend Yield
  • 0
  • MACD Signal
  • -2.2
  • RSI
  • 35.4
  • MFI
  • 42.08

Sakar Healthcare Financials

Sakar Healthcare Technicals

EMA & SMA

Current Price
₹287.60
-6.3 (-2.14%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹308.87
  • 50 Day
  • ₹313.92
  • 100 Day
  • ₹320.75
  • 200 Day
  • ₹328.22

Resistance and Support

294.63 Pivot Speed
  • R3 305.67
  • R2 302.23
  • R1 298.07
  • S1 290.47
  • S2 287.03
  • S3 282.87

What's your outlook on Sakar Healthcare?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sakar Healthcare has an operating revenue of Rs. 164.21 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 10% is healthy, ROE of 4% is fair but needs improvement. The company has a reasonable debt to equity of 21%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 47 which is a POOR score indicating inconsistency in earnings, a RS Rating of 15 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 29 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sakar Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-22 Quarterly Results
2024-08-13 Quarterly Results
2024-05-21 Audited results
2024-02-10 Quarterly Results
2023-11-06 Quarterly Results

Sakar Healthcare F&O

Sakar Healthcare Shareholding Pattern

53.15%
13.42%
16.87%
16.56%

About Sakar Healthcare

  • NSE Symbol
  • SAKAR
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Sanjay S Shah
  • ISIN
  • INE732S01012

Similar Stocks to Sakar Healthcare

Sakar Healthcare FAQs

Sakar Healthcare share price is ₹287 As on 21 November, 2024 | 13:57

The Market Cap of Sakar Healthcare is ₹614 Cr As on 21 November, 2024 | 13:57

The P/E ratio of Sakar Healthcare is 49.5 As on 21 November, 2024 | 13:57

The PB ratio of Sakar Healthcare is 2.3 As on 21 November, 2024 | 13:57

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23